<html><head><link rel="stylesheet" type="text/css" href="usc.css"/><title>U.S.C. Title 42 - THE PUBLIC HEALTH AND WELFARE</title></html></head>
<span style="font-weight:bold;font-size:12pt;">42 U.S.C. </span><br/>
<span style="font-size:10pt">United States Code, 2006 Edition</span><br/>
<span style="font-size:10pt">Title 42 - THE PUBLIC HEALTH AND WELFARE</span><br/>
<span style="font-size:10pt">CHAPTER 6A - PUBLIC HEALTH SERVICE</span><br/>
<span style="font-size:10pt">SUBCHAPTER IX - GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME</span><br/>
<span style="font-size:10pt">Part A - Genetic Diseases</span><br/>
<span style="font-size:10pt">From the U.S. Government Printing Office, <a href="http://www.gpo.gov">www.gpo.gov</a></span><br/><br/>
<!-- documentid:42_-ch6A-scIX-Part_A currentthrough:20070103 documentPDFPage:781 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A -->
<!-- itemsortkey:420ABKX -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases -->
<!-- field-start:structuralhead -->
<h3 class="part-head"><cap-smallcap>Part A&mdash;Genetic Diseases</cap-smallcap></h3>
<!-- field-end:structuralhead -->
<!-- field-start:notes -->
<!-- field-start:amendment-note -->
<h4 class="note-head">Amendments</h4>
<p class="note-body">1976&mdash;Pub. L. 94&ndash;278, title IV, &sect;403(a), Apr. 22, 1976, 90 Stat. 407, substituted &ldquo;Genetic Diseases&rdquo; for &ldquo;Sickle Cell Anemia Programs&rdquo; in part A heading.</p>
<!-- field-end:amendment-note -->
<!-- field-end:notes -->

<!-- documentid:42_300b  usckey:420000000030000000000000b00000000 currentthrough:20070103 documentPDFPage:781 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A/Sec. 300b -->
<!-- itemsortkey:420ABKY -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases!@!Sec. 300b -->
<!-- field-start:repealedhead -->
<h3 class="section-head">&sect;300b. Repealed. Pub. L. 97&ndash;35, title XXI, &sect;2193(b)(1), Aug. 13, 1981, 95 Stat. 827</h3>
<!-- field-end:repealedhead -->
<!-- field-start:repealsummary -->
<p class="note-body">Section, act July 1, 1944, ch. 373, title XI, &sect;1101, as added Apr. 22, 1976, Pub. L. 94&ndash;278, title IV, &sect;403(a), 90 Stat. 407; amended Nov. 10, 1978, Pub. L. 95&ndash;626, title II, &sect;205(b), (d)(2), (e), 92 Stat. 3583, 3584; Pub. L. 96&ndash;88, title V, &sect;509(b), Oct. 17, 1979, 93 Stat. 695; Aug. 13, 1981, Pub. L. 97&ndash;35, title XXI, &sect;2193(a)(1)(B), 95 Stat. 826; Jan. 4, 1983, Pub. L. 97&ndash;414, &sect;8(<em>o</em>), 96 Stat. 2061, related to testing, counseling, information and education programs.</p>
<p class="note-body">A prior section 300b, act July 1, 1944, ch. 373, title XI, &sect;1101, as added May 16, 1972, Pub. L. 92&ndash;294, &sect;3(c), 86 Stat. 137; amended Aug. 29, 1972, Pub. L. 92&ndash;414, &sect;4(2), 86 Stat. 652, authorized Secretary to make grants and enter contracts with public and nonprofit private entities with respect to establishment of voluntary sickle cell anemia screening and counseling programs and to develop and disseminate informational and educational materials relating to sickle cell anemia, prior to repeal by Pub. L. 94&ndash;278, title IV, &sect;403(a), Apr. 22, 1976, 90 Stat. 407.</p>
<!-- field-end:repealsummary -->
<!-- field-start:notes -->
<!-- field-start:effectivedate-repeal-amendment-note -->
<h4 class="note-head">Effective Date of 1981 Amendment and Repeal, Savings, and Transitional Provisions</h4>
<p class="note-body">For effective date, savings, and transitional provisions relating to the amendment and repeal of this section by Pub. L. 97&ndash;35, see section 2194 of Pub. L. 97&ndash;35, set out as a note under section 701 of this title.</p>
<!-- field-end:effectivedate-repeal-amendment-note -->
<!-- field-end:notes -->

<!-- documentid:42_300b-1  usckey:420000000030000000000000b00010000 currentthrough:20070103 documentPDFPage:781 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A/Sec. 300b-1 -->
<!-- itemsortkey:420ABKZ -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases!@!Sec. 300b-1 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;300b&ndash;1. Research project grants and contracts</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<p class="statutory-body">In carrying out section 241 of this title, the Secretary may make grants to public and nonprofit private entities, and may enter into contracts with public and private entities and individuals, for projects for (1) basic or applied research leading to the understanding, diagnosis, treatment, and control of genetic diseases, (2) planning, establishing, demonstrating, and developing special programs for the training of genetic counselors, social and behavioral scientists, and other health professionals, (3) the development of programs to educate practicing physicians, other health professionals, and the public regarding the nature of genetic processes, the inheritance patterns of genetic diseases, and the means, methods, and facilities available to diagnose, control, counsel, and treat genetic diseases, and (4) the development of counseling and testing programs and other programs for the diagnosis, control, and treatment of genetic diseases. In making grants and entering into contracts for projects described in clause (1) of the preceding sentence, the Secretary shall give priority to applications for such grants or contracts which are submitted for research on sickle cell anemia and for research on Cooley's anemia.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title XI, &sect;1102, as added Pub. L. 94&ndash;278, title IV, &sect;403(a), Apr. 22, 1976, 90 Stat. 408.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:priorprovisions-note -->
<h4 class="note-head">Prior Provisions</h4>
<p class="note-body">A prior section 300b&ndash;1, act July 1, 1944, ch. 373, title XI, &sect;1102, as added May 16, 1972, Pub. L. 92&ndash;294, &sect;3(c), 86 Stat. 138, authorized Secretary to make grants and enter contracts with public and private entities and individuals for projects concerned with research, research training in diagnosis, treatment and control of sickle cell anemia, informational and educational programs with respect to sickle cell anemia and development of counseling and testing programs, prior to repeal by Pub. L. 94&ndash;278, title IV, &sect;403(a), Apr. 22, 1976, 90 Stat. 407.</p>
<!-- field-end:priorprovisions-note -->
<!-- field-start:effectivedate-note -->
<h4 class="note-head">Effective Date</h4>
<p class="note-body">Section 403(c) of Pub. L. 94&ndash;278 provided that: &ldquo;The amendments made by subsections (a) and (b) [see section 401 of Pub. L. 94&ndash;278, set out as a Short Title of 1976 Amendment note under section 201 of this title] shall take effect July 1, 1976.&rdquo;</p>
<!-- field-end:effectivedate-note -->
<!-- field-start:shorttitle-amendment-note -->
<h4 class="note-head">Short Title of 1976 Amendment</h4>
<p class="note-body">For short title of title IV of Pub. L. 94&ndash;278, which enacted this part, omitted former part B of this subchapter, redesignated former parts C and D of this subchapter as parts B and C of this subchapter, respectively, as the &ldquo;National Sickle Cell Anemia, Cooley's Anemia, Tay-Sachs, and Genetic Diseases Act&rdquo;, see section 401 of Pub. L. 94&ndash;278, set out as a note under section 201 of this title.</p>
<!-- field-end:shorttitle-amendment-note -->
<!-- field-start:miscellaneous-note -->
<h4 class="note-head">Demonstration Program for the Development and Establishment of Systemic Mechanisms for the Prevention and Treatment of Sickle Cell Disease</h4>
<p class="note-body">Pub. L. 108&ndash;357, title VII, &sect;712(c), Oct. 22, 2004, 118 Stat. 1559, provided that:</p>
<p class="note-body">&ldquo;(1) <cap-smallcap>Authority to conduct demonstration program.&mdash;</cap-smallcap></p>
<p class="note-body-1em">&ldquo;(A) <cap-smallcap>In general</cap-smallcap>.&mdash;The Administrator, through the Bureau of Primary Health Care and the Maternal and Child Health Bureau, shall conduct a demonstration program by making grants to up to 40 eligible entities for each fiscal year in which the program is conducted under this section [probably means this subsection] for the purpose of developing and establishing systemic mechanisms to improve the prevention and treatment of Sickle Cell Disease, including through&mdash;</p>
<p class="note-body-2em">&ldquo;(i) the coordination of service delivery for individuals with Sickle Cell Disease;</p>
<p class="note-body-2em">&ldquo;(ii) genetic counseling and testing;</p>
<p class="note-body-2em">&ldquo;(iii) bundling of technical services related to the prevention and treatment of Sickle Cell Disease;</p>
<p class="note-body-2em">&ldquo;(iv) training of health professionals; and</p>
<p class="note-body-2em">&ldquo;(v) identifying and establishing other efforts related to the expansion and coordination of education, treatment, and continuity of care programs for individuals with Sickle Cell Disease.</p>
<p class="note-body-1em">&ldquo;(B) <cap-smallcap>Grant award requirements.&mdash;</cap-smallcap></p>
<p class="note-body-2em">&ldquo;(i) <cap-smallcap>Geographic diversity</cap-smallcap>.&mdash;The Administrator shall, to the extent practicable, award grants under <!-- PDFPage:782 -->this section [probably means this subsection] to eligible entities located in different regions of the United States.</p>
<p class="note-body-2em">&ldquo;(ii) <cap-smallcap>Priority</cap-smallcap>.&mdash;In awarding grants under this subsection, the Administrator shall give priority to awarding grants to eligible entities that are&mdash;</p>
<p class="note-body-3em">&ldquo;(I) Federally-qualified health centers that have a partnership or other arrangement with a comprehensive Sickle Cell Disease treatment center that does not receive funds from the National Institutes of Health; or</p>
<p class="note-body-3em">&ldquo;(II) Federally-qualified health centers that intend to develop a partnership or other arrangement with a comprehensive Sickle Cell Disease treatment center that does not receive funds from the National Institutes of Health.</p>
<p class="note-body">&ldquo;(2) <cap-smallcap>Additional requirements</cap-smallcap>.&mdash;An eligible entity awarded a grant under this subsection shall use funds made available under the grant to carry out, in addition to the activities described in paragraph (1)(A), the following activities:</p>
<p class="note-body-1em">&ldquo;(A) To facilitate and coordinate the delivery of education, treatment, and continuity of care for individuals with Sickle Cell Disease under&mdash;</p>
<p class="note-body-2em">&ldquo;(i) the entity's collaborative agreement with a community-based Sickle Cell Disease organization or a nonprofit entity that works with individuals who have Sickle Cell Disease;</p>
<p class="note-body-2em">&ldquo;(ii) the Sickle Cell Disease newborn screening program for the State in which the entity is located; and</p>
<p class="note-body-2em">&ldquo;(iii) the maternal and child health program under title V of the Social Security Act (42 U.S.C. 701 et seq.) for the State in which the entity is located.</p>
<p class="note-body-1em">&ldquo;(B) To train nursing and other health staff who provide care for individuals with Sickle Cell Disease.</p>
<p class="note-body-1em">&ldquo;(C) To enter into a partnership with adult or pediatric hematologists in the region and other regional experts in Sickle Cell Disease at tertiary and academic health centers and State and county health offices.</p>
<p class="note-body-1em">&ldquo;(D) To identify and secure resources for ensuring reimbursement under the medicaid program, State children's health insurance program, and other health programs for the prevention and treatment of Sickle Cell Disease.</p>
<p class="note-body">&ldquo;(3) <cap-smallcap>National coordinating center.&mdash;</cap-smallcap></p>
<p class="note-body-1em">&ldquo;(A) <cap-smallcap>Establishment</cap-smallcap>.&mdash;The Administrator shall enter into a contract with an entity to serve as the National Coordinating Center for the demonstration program conducted under this subsection.</p>
<p class="note-body-1em">&ldquo;(B) <cap-smallcap>Activities described</cap-smallcap>.&mdash;The National Coordinating Center shall&mdash;</p>
<p class="note-body-2em">&ldquo;(i) collect, coordinate, monitor, and distribute data, best practices, and findings regarding the activities funded under grants made to eligible entities under the demonstration program;</p>
<p class="note-body-2em">&ldquo;(ii) develop a model protocol for eligible entities with respect to the prevention and treatment of Sickle Cell Disease;</p>
<p class="note-body-2em">&ldquo;(iii) develop educational materials regarding the prevention and treatment of Sickle Cell Disease; and</p>
<p class="note-body-2em">&ldquo;(iv) prepare and submit to Congress a final report that includes recommendations regarding the effectiveness of the demonstration program conducted under this subsection and such direct outcome measures as&mdash;</p>
<p class="note-body-3em">&ldquo;(I) the number and type of health care resources utilized (such as emergency room visits, hospital visits, length of stay, and physician visits for individuals with Sickle Cell Disease); and</p>
<p class="note-body-3em">&ldquo;(II) the number of individuals that were tested and subsequently received genetic counseling for the sickle cell trait.</p>
<p class="note-body">&ldquo;(4) <cap-smallcap>Application</cap-smallcap>.&mdash;An eligible entity desiring a grant under this subsection shall submit an application to the Administrator at such time, in such manner, and containing such information as the Administrator may require.</p>
<p class="note-body">&ldquo;(5) <cap-smallcap>Definitions</cap-smallcap>.&mdash;In this subsection:</p>
<p class="note-body-1em">&ldquo;(A) <cap-smallcap>Administrator</cap-smallcap>.&mdash;The term &lsquo;Administrator&rsquo; means the Administrator of the Health Resources and Services Administration.</p>
<p class="note-body-1em">&ldquo;(B) <cap-smallcap>Eligible entity</cap-smallcap>.&mdash;The term &lsquo;eligible entity&rsquo; means a Federally-qualified health center, a nonprofit hospital or clinic, or a university health center that provides primary health care, that&mdash;</p>
<p class="note-body-2em">&ldquo;(i) has a collaborative agreement with a community-based Sickle Cell Disease organization or a nonprofit entity with experience in working with individuals who have Sickle Cell Disease; and</p>
<p class="note-body-2em">&ldquo;(ii) demonstrates to the Administrator that either the Federally-qualified health center, the nonprofit hospital or clinic, the university health center, the organization or entity described in clause (i), or the experts described in paragraph (2)(C), has at least 5 years of experience in working with individuals who have Sickle Cell Disease.</p>
<p class="note-body-1em">&ldquo;(C) <cap-smallcap>Federally-qualified health center</cap-smallcap>.&mdash;The term &lsquo;Federally-qualified health center&rsquo; has the meaning given that term in section 1905(<em>l</em>)(2)(B) of the Social Security Act (42 U.S.C. 1396d(<em>l</em>)(2)(B)).</p>
<p class="note-body">&ldquo;(6) <cap-smallcap>Authorization of appropriations</cap-smallcap>.&mdash;There is authorized to be appropriated to carry out this subsection, $10,000,000 for each of fiscal years 2005 through 2009.&rdquo;</p>
<h4 class="note-head">Congressional Declaration of Purpose</h4>
<p class="note-body">Section 402 of Pub. L. 94&ndash;278, as amended by Pub. L. 95&ndash;626, title II, &sect;205(a), Nov. 10, 1978, 92 Stat. 3583, provided that: &ldquo;In order to preserve and protect the health and welfare of all citizens, it is the purpose of this title [see section 401 of Pub. L. 94&ndash;278, set out as a Short Title of 1976 Amendment note under section 201 of this title] to establish a national program to provide for basic and applied research, research training, testing, counseling, and information and education programs with respect to genetic diseases, and genetic conditions, such as Sickle Cell anemia, Cooley's Anemia, Tay&ndash;Sachs disease, cystic fibrosis, dysautonomia, hemophilia, retinitis pigmentosa, Huntington's chorea, muscular dystrophy, and genetic conditions leading to mental retardation or genetically caused mental disorders.&rdquo;</p>
<!-- field-end:miscellaneous-note -->
<!-- field-end:notes -->

<!-- documentid:42_300b-2  usckey:420000000030000000000000b00020000 currentthrough:20070103 documentPDFPage:782 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A/Sec. 300b-2 -->
<!-- itemsortkey:420ABLA -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases!@!Sec. 300b-2 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;300b&ndash;2. Voluntary participation by individuals</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<p class="statutory-body">The participation by any individual in any program or portion thereof under this part shall be wholly voluntary and shall not be a prerequisite to eligibility for or receipt of any other service or assistance from, or to participation in, any other program.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title XI, &sect;1103, as added Pub. L. 94&ndash;278, title IV, &sect;403(a), Apr. 22, 1976, 90 Stat. 408.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:priorprovisions-note -->
<h4 class="note-head">Prior Provisions</h4>
<p class="note-body">A prior section 300b&ndash;2, act July 1, 1944, ch. 373, title XI, &sect;1103, as added May 16, 1972, Pub. L. 92&ndash;294, &sect;3(c), 86 Stat. 138; amended Aug. 29, 1972, Pub. L. 92&ndash;414, &sect;4(3), 86 Stat. 652, was identical to this section, prior to repeal by Pub. L. 94&ndash;278, title IV, &sect;403(a), Apr. 22, 1976, 90 Stat. 407.</p>
<!-- field-end:priorprovisions-note -->
<!-- field-end:notes -->

<!-- documentid:42_300b-3  usckey:420000000030000000000000b00030000 currentthrough:20070103 documentPDFPage:782 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A/Sec. 300b-3 -->
<!-- itemsortkey:420ABLB -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases!@!Sec. 300b-3 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;300b&ndash;3. Application; special consideration to prior sickle cell anemia grant recipients</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) Manner of submission; contents</h4>
<p class="statutory-body">A grant or contract under this part may be made upon application submitted to the Secretary at such time, in such manner, and containing and accompanied by such information, as the Secretary may require, including assurances for an evaluation whether performed by the applicant or by the Secretary. Such grant or <!-- PDFPage:783 -->contract may be made available on less than a statewide or regional basis. Each applicant shall&mdash;</p>
<p class="statutory-body-1em">(1) provide that the programs and activities for which assistance under this part is sought will be administered by or under the supervision of the applicant;</p>
<p class="statutory-body-1em">(2) provide for strict confidentiality of all test results, medical records, and other information regarding testing, diagnosis, counseling, or treatment of any person treated, except for (A) such information as the patient (or his guardian) gives informed consent to be released, or (B) statistical data compiled without reference to the identity of any such patient;</p>
<p class="statutory-body-1em">(3) provide for community representation where appropriate in the development and operation of voluntary genetic testing or counseling programs funded by a grant or contract under this part; and</p>
<p class="statutory-body-1em">(4) establish fiscal control and fund accounting procedures as may be necessary to assure proper disbursement of and accounting of Federal funds paid to the applicant under this part.</p>
<h4 class="subsection-head">(b) Considerations for grants and contracts under section 300b&ndash;1 of this title</h4>
<p class="statutory-body">In making grants and entering into contracts for any fiscal year under section 241 of this title for projects described in section 300b&ndash;1 of this title the Secretary shall give special consideration to applications from entities that received grants from, or entered into contracts with, the Secretary for the preceding fiscal year for the conduct of comprehensive sickle cell centers or sickle cell screening and education clinics.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title XI, &sect;1104, as added Pub. L. 94&ndash;278, title IV, &sect;403(a), Apr. 22, 1976, 90 Stat. 408; amended Pub. L. 95&ndash;626, title II, &sect;205(c), Nov. 10, 1978, 92 Stat. 3584; Pub. L. 97&ndash;35, title XXI, &sect;2193(b)(2), (3), Aug. 13, 1981, 95 Stat. 827.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:priorprovisions-note -->
<h4 class="note-head">Prior Provisions</h4>
<p class="note-body">A prior section 300b&ndash;3, act July 1, 1944, ch. 373, title XI, &sect;1104, as added May 16, 1972, Pub. L. 92&ndash;294, &sect;3(c), 86 Stat. 138; amended Aug. 29, 1972, Pub. L. 92&ndash;414, &sect;4(3), 86 Stat. 652, authorized grants to be made upon application to Secretary and required supervision of programs by applicant, confidentiality of test results, medical records and other information obtained from treated person, community representation in programs, assurances by applicant that priority will be given to persons of child bearing years, and demonstration by applicant of proper fiscal control and accounting procedures, prior to repeal by Pub. L. 94&ndash;278, title IV, &sect;403(a), Apr. 22, 1976, 90 Stat. 407.</p>
<!-- field-end:priorprovisions-note -->
<!-- field-start:amendment-note -->
<h4 class="note-head">Amendments</h4>
<p class="note-body">1981&mdash;Subsec. (a)(4), (5). Pub. L. 97&ndash;35, &sect;2193(b)(2), redesignated par. (5) as (4). Former par. (4), which related to testing and counseling requirements, was struck out.</p>
<p class="note-body">Subsec. (b). Pub. L. 97&ndash;35, &sect;2193(b)(3), struck out subsec. (b) which related to grants and contracts under section 300b of this title. Former subsec. (c) was redesignated (b) and, as so redesignated, struck out reference to section 300b of this title.</p>
<p class="note-body">Subsec. (c). Pub. L. 97&ndash;35, &sect;2193(b)(3), redesignated subsec. (c) as (b).</p>
<p class="note-body">Subsec. (d). Pub. L. 97&ndash;35, &sect;2193(b)(3), struck out subsec. (d) which related to procedures applicable to grants, etc., under section 300b of this title.</p>
<p class="note-body">1978&mdash;Subsec. (a). Pub. L. 95&ndash;626, &sect;205(c)(1), inserted requirement that application contain assurances for an evaluation whether performed by applicant or by Secretary and that grant or contract be made available on less than a statewide or regional basis.</p>
<p class="note-body">Subsec. (d). Pub. L. 95&ndash;626, &sect;205(c)(2), added subsec. (d).</p>
<!-- field-end:amendment-note -->
<!-- field-start:effectivedate-amendment-note -->
<h4 class="note-head">Effective Date of 1981 Amendment, Savings, and Transitional Provisions</h4>
<p class="note-body">For effective date, savings, and transitional provisions relating to amendment by Pub. L. 97&ndash;35, see section 2194 of Pub. L. 97&ndash;35, set out as a note under section 701 of this title.</p>
<!-- field-end:effectivedate-amendment-note -->
<!-- field-end:notes -->

<!-- documentid:42_300b-4  usckey:420000000030000000000000b00040000 currentthrough:20070103 documentPDFPage:783 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A/Sec. 300b-4 -->
<!-- itemsortkey:420ABLC -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases!@!Sec. 300b-4 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;300b&ndash;4. Public Health Service facilities</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<p class="statutory-body">The Secretary shall establish a program within the Service to provide voluntary testing, diagnosis, counseling, and treatment of individuals respecting genetic diseases. Services under such program shall be made available through facilities of the Service to persons requesting such services, and the program shall provide appropriate publicity of the availability and voluntary nature of such services.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title XI, &sect;1105, as added Pub. L. 94&ndash;278, title IV, &sect;403(a), Apr. 22, 1976, 90 Stat. 409.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:priorprovisions-note -->
<h4 class="note-head">Prior Provisions</h4>
<p class="note-body">A prior section 300b&ndash;4, act July 1, 1944, ch. 373, title XI, &sect;1105, as added May 16, 1972, Pub. L. 92&ndash;294, &sect;3(c), 86 Stat. 139, authorized Secretary to establish a program within the Public Health Service with respect to sickle cell anemia with such program to be made available through facilities of Public Health Service, prior to repeal by Pub. L. 94&ndash;278, title IV, &sect;403(a), Apr. 22, 1976, 90 Stat. 407.</p>
<!-- field-end:priorprovisions-note -->
<!-- field-end:notes -->

<!-- documentid:42_300b-5  usckey:420000000030000000000000b00050000 currentthrough:20070103 documentPDFPage:783 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A/Sec. 300b-5 -->
<!-- itemsortkey:420ABLD -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases!@!Sec. 300b-5 -->
<!-- field-start:repealedhead -->
<h3 class="section-head">&sect;300b&ndash;5. Repealed. Pub. L. 97&ndash;35, title XXI, &sect;2193(b)(4), Aug. 13, 1981, 95 Stat. 827</h3>
<!-- field-end:repealedhead -->
<!-- field-start:repealsummary -->
<p class="note-body">Section, act July 1, 1944, ch. 373, title XI, &sect;1106, as added Apr. 22, 1976, Pub. L. 94&ndash;278, title IV, &sect;403(a), 90 Stat. 409, related to an annual report to President and Congress on administration of this part.</p>
<p class="note-body">A prior section 300b&ndash;5, act July 1, 1944, ch. 373, title XI, &sect;1106, as added May 16, 1972, Pub. L. 92&ndash;294, &sect;3(c), 86 Stat. 139; amended Aug. 29, 1972, Pub. L. 92&ndash;414, &sect;4(3), 86 Stat. 652, related to an annual report to President and Congress on administration of this part, prior to repeal by Pub. L. 94&ndash;278, title IV, &sect;403(a), Apr. 22, 1976, 90 Stat. 407.</p>
<!-- field-end:repealsummary -->
<!-- field-start:notes -->
<!-- field-start:effectivedate-repeal-note -->
<h4 class="note-head">Effective Date of Repeal, Savings, and Transitional Provisions</h4>
<p class="note-body">For effective date, savings, and transitional provisions relating to repeal by Pub. L. 97&ndash;35, see section 2194 of Pub. L. 97&ndash;35, set out as a note under section 701 of this title.</p>
<!-- field-end:effectivedate-repeal-note -->
<!-- field-end:notes -->

<!-- documentid:42_300b-6  usckey:420000000030000000000000b00060000 currentthrough:20070103 documentPDFPage:783 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A/Sec. 300b-6 -->
<!-- itemsortkey:420ABLE -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases!@!Sec. 300b-6 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;300b&ndash;6. Applied technology</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<p class="statutory-body">The Secretary, acting through an identifiable administrative unit, shall&mdash;</p>
<p class="statutory-body-1em">(1) conduct epidemiological assessments and surveillance of genetic diseases to define the scope and extent of such diseases and the need for programs for the diagnosis, treatment, and control of such diseases, screening for such diseases, and the counseling of persons with such diseases;</p>
<p class="statutory-body-1em">(2) on the basis of the assessments and surveillance described in paragraph (1), develop for use by the States programs which combine <!-- PDFPage:784 -->in an effective manner diagnosis, treatment, and control of such diseases, screening for such diseases, and counseling of persons with such diseases; and</p>
<p class="statutory-body-1em">(3) on the basis of the assessments and surveillance described in paragraph (1), provide technical assistance to States to implement the programs developed under paragraph (2) and train appropriate personnel for such programs.</p>
<br class="Q04" />
<p class="statutory-body-block">In carrying out this section, the Secretary may, from funds allotted for use under section 702(a) of this title, make grants to or contracts with public or nonprofit private entities (including grants and contracts for demonstration projects).</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title XI, &sect;1107, as added Pub. L. 95&ndash;626, title II, &sect;205(d)(1), Nov. 10, 1978, 92 Stat. 3584; amended Pub. L. 97&ndash;35, title XXI, &sect;2193(b)(5), Aug. 13, 1981, 95 Stat. 827.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:amendment-note -->
<h4 class="note-head">Amendments</h4>
<p class="note-body">1981&mdash;Pub. L. 97&ndash;35 substituted provisions relating to allotments under section 702(a) of this title for provisions relating to appropriations under section 300b(b) of this title.</p>
<!-- field-end:amendment-note -->
<!-- field-start:effectivedate-amendment-note -->
<h4 class="note-head">Effective Date of 1981 Amendment, Savings, and Transitional Provisions</h4>
<p class="note-body">For effective date, savings, and transitional provisions relating to amendment by Pub. L. 97&ndash;35, see section 2194 of Pub. L. 97&ndash;35, set out as a note under section 701 of this title.</p>
<!-- field-end:effectivedate-amendment-note -->
<!-- field-end:notes -->

<!-- documentid:42_300b-7  usckey:420000000030000000000000b00070000 currentthrough:20070103 documentPDFPage:784 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A/Sec. 300b-7 -->
<!-- itemsortkey:420ABLF -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases!@!Sec. 300b-7 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;300b&ndash;7. Tourette Syndrome</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) In general</h4>
<p class="statutory-body">The Secretary shall develop and implement outreach programs to educate the public, health care providers, educators and community based organizations about the etiology, symptoms, diagnosis and treatment of Tourette Syndrome, with a particular emphasis on children with Tourette Syndrome. Such programs may be carried out by the Secretary directly and through awards of grants or contracts to public or nonprofit private entities.</p>
<h4 class="subsection-head">(b) Certain activities</h4>
<p class="statutory-body">Activities under subsection (a) of this section shall include&mdash;</p>
<p class="statutory-body-1em">(1) the production and translation of educational materials, including public service announcements;</p>
<p class="statutory-body-1em">(2) the development of training material for health care providers, educators and community based organizations; and</p>
<p class="statutory-body-1em">(3) outreach efforts directed at the misdiagnosis and underdiagnosis of Tourette Syndrome in children and in minority groups.</p>
<h4 class="subsection-head">(c) Authorization of appropriations</h4>
<p class="statutory-body">For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2001 through 2005.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title XI, &sect;1108, as added Pub. L. 106&ndash;310, div. A, title XXIII, &sect;2301, Oct. 17, 2000, 114 Stat. 1157.)</p>
<!-- field-end:sourcecredit -->

<!-- documentid:42_300b-8  usckey:420000000030000000000000b00080000 currentthrough:20070103 documentPDFPage:784 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A/Sec. 300b-8 -->
<!-- itemsortkey:420ABLG -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases!@!Sec. 300b-8 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;300b&ndash;8. Improved newborn and child screening for heritable disorders</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) In general</h4>
<p class="statutory-body">The Secretary shall award grants to eligible entities to enhance, improve or expand the ability of State and local public health agencies to provide screening, counseling or health care services to newborns and children having or at risk for heritable disorders.</p>
<h4 class="subsection-head">(b) Use of funds</h4>
<p class="statutory-body">Amounts provided under a grant awarded under subsection (a) of this section shall be used to&mdash;</p>
<p class="statutory-body-1em">(1) establish, expand, or improve systems or programs to provide screening, counseling, testing or specialty services for newborns and children at risk for heritable disorders;</p>
<p class="statutory-body-1em">(2) establish, expand, or improve programs or services to reduce mortality or morbidity from heritable disorders;</p>
<p class="statutory-body-1em">(3) establish, expand, or improve systems or programs to provide information and counseling on available therapies for newborns and children with heritable disorders;</p>
<p class="statutory-body-1em">(4) improve the access of medically underserved populations to screening, counseling, testing and specialty services for newborns and children having or at risk for heritable disorders; or</p>
<p class="statutory-body-1em">(5) conduct such other activities as may be necessary to enable newborns and children having or at risk for heritable disorders to receive screening, counseling, testing or specialty services, regardless of income, race, color, religion, sex, national origin, age, or disability.</p>
<h4 class="subsection-head">(c) Eligible entities</h4>
<p class="statutory-body">To be eligible to receive a grant under subsection (a) of this section an entity shall&mdash;</p>
<p class="statutory-body-1em">(1) be a State or political subdivision of a State, or a consortium of two or more States or political subdivisions of States; and</p>
<p class="statutory-body-1em">(2) prepare and submit to the Secretary an application that includes&mdash;</p>
<p class="statutory-body-2em">(A) a plan to use amounts awarded under the grant to meet specific health status goals and objectives relative to heritable disorders, including attention to needs of medically underserved populations;</p>
<p class="statutory-body-2em">(B) a plan for the collection of outcome data or other methods of evaluating the degree to which amounts awarded under this grant will be used to achieve the goals and objectives identified under subparagraph (A);</p>
<p class="statutory-body-2em">(C) a plan for monitoring and ensuring the quality of services provided under the grant;</p>
<p class="statutory-body-2em">(D) an assurance that amounts awarded under the grant will be used only to implement the approved plan for the State;</p>
<p class="statutory-body-2em">(E) an assurance that the provision of services under the plan is coordinated with services provided under programs implemented in the State under title V, XVIII, XIX, XX, or XXI of the Social Security Act [42 U.S.C. 701 et seq., 1395 et seq., 1396 et seq. 1397 et seq., 1397aa et seq.] (subject to Federal regulations applicable to such programs) so that the coverage of services under such titles is not substantially diminished by the use of granted funds; and</p>
<!-- PDFPage:785 --><p class="statutory-body-2em">(F) such other information determined by the Secretary to be necessary.</p>
<h4 class="subsection-head">(d) Limitation</h4>
<p class="statutory-body">An eligible entity may not use amounts received under this section to&mdash;</p>
<p class="statutory-body-1em">(1) provide cash payments to or on behalf of affected individuals;</p>
<p class="statutory-body-1em">(2) provide inpatient services;</p>
<p class="statutory-body-1em">(3) purchase land or make capital improvements to property; or</p>
<p class="statutory-body-1em">(4) provide for proprietary research or training.</p>
<h4 class="subsection-head">(e) Voluntary participation</h4>
<p class="statutory-body">The participation by any individual in any program or portion thereof established or operated with funds received under this section shall be wholly voluntary and shall not be a prerequisite to eligibility for or receipt of any other service or assistance from, or to participation in, another Federal or State program.</p>
<h4 class="subsection-head">(f) Supplement not supplant</h4>
<p class="statutory-body">Funds appropriated under this section shall be used to supplement and not supplant other Federal, State, and local public funds provided for activities of the type described in this section.</p>
<h4 class="subsection-head">(g) Publication</h4>
<h4 class="paragraph-head">(1) In general</h4>
<p class="statutory-body-1em">An application submitted under subsection (c)(2) of this section shall be made public by the State in such a manner as to facilitate comment from any person, including through hearings and other methods used to facilitate comments from the public.</p>
<h4 class="paragraph-head">(2) Comments</h4>
<p class="statutory-body-1em">Comments received by the State after the publication described in paragraph (1) shall be addressed in the application submitted under subsection (c)(2) of this section.</p>
<h4 class="subsection-head">(h) Technical assistance</h4>
<p class="statutory-body">The Secretary shall provide to entities receiving grants under subsection (a) of this section such technical assistance as may be necessary to ensure the quality of programs conducted under this section.</p>
<h4 class="subsection-head">(i) Authorization of appropriations</h4>
<p class="statutory-body">There are authorized to be appropriated to carry out this section such sums as may be necessary for each of the fiscal years 2001 through 2005.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title XI, &sect;1109, as added Pub. L. 106&ndash;310, div. A, title XXVI, &sect;2601, Oct. 17, 2000, 114 Stat. 1164.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:referenceintext-note -->
<h4 class="note-head">References in Text</h4>
<p class="note-body">The Social Security Act, referred to in subsec. (c)(2)(E), is act Aug. 14, 1935, ch. 531, 49 Stat. 620, as amended. Titles V, XVIII, XIX, XX, and XXI of the Act are classified generally to subchapters V (&sect;701 et seq.), XVIII (&sect;1395 et seq.), XIX (&sect;1396 et seq.), XX (&sect;1397 et seq.), and XXI (&sect;1397aa et seq.), respectively, of chapter 7 of this title. For complete classification of this Act to the Code, see section 1305 of this title and Tables.</p>
<!-- field-end:referenceintext-note -->
<!-- field-end:notes -->

<!-- documentid:42_300b-9  usckey:420000000030000000000000b00090000 currentthrough:20070103 documentPDFPage:785 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A/Sec. 300b-9 -->
<!-- itemsortkey:420ABLH -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases!@!Sec. 300b-9 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;300b&ndash;9. Evaluating the effectiveness of newborn and child screening programs</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) In general</h4>
<p class="statutory-body">The Secretary shall award grants to eligible entities to provide for the conduct of demonstration programs to evaluate the effectiveness of screening, counseling or health care services in reducing the morbidity and mortality caused by heritable disorders in newborns and children.</p>
<h4 class="subsection-head">(b) Demonstration programs</h4>
<p class="statutory-body">A demonstration program conducted under a grant under this section shall be designed to evaluate and assess, within the jurisdiction of the entity receiving such grant&mdash;</p>
<p class="statutory-body-1em">(1) the effectiveness of screening, counseling, testing or specialty services for newborns and children at risk for heritable disorders in reducing the morbidity and mortality associated with such disorders;</p>
<p class="statutory-body-1em">(2) the effectiveness of screening, counseling, testing or specialty services in accurately and reliably diagnosing heritable disorders in newborns and children; or</p>
<p class="statutory-body-1em">(3) the availability of screening, counseling, testing or specialty services for newborns and children at risk for heritable disorders.</p>
<h4 class="subsection-head">(c) Eligible entities</h4>
<p class="statutory-body">To be eligible to receive a grant under subsection (a) of this section an entity shall be a State or political subdivision of a State, or a consortium of two or more States or political subdivisions of States.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title XI, &sect;1110, as added Pub. L. 106&ndash;310, div. A, title XXVI, &sect;2601, Oct. 17, 2000, 114 Stat. 1165.)</p>
<!-- field-end:sourcecredit -->

<!-- documentid:42_300b-10  usckey:420000000030000000000000b00100000 currentthrough:20070103 documentPDFPage:785 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A/Sec. 300b-10 -->
<!-- itemsortkey:420ABLI -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases!@!Sec. 300b-10 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;300b&ndash;10. Advisory Committee on Heritable Disorders in Newborns and Children</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) Establishment</h4>
<p class="statutory-body">The Secretary shall establish an advisory committee to be known as the &ldquo;Advisory Committee on Heritable Disorders in Newborns and Children&rdquo; (referred to in this section as the &ldquo;Advisory Committee&rdquo;).</p>
<h4 class="subsection-head">(b) Duties</h4>
<p class="statutory-body">The Advisory Committee shall&mdash;</p>
<p class="statutory-body-1em">(1) provide advice and recommendations to the Secretary concerning grants and projects awarded or funded under section 300b&ndash;8 of this title;</p>
<p class="statutory-body-1em">(2) provide technical information to the Secretary for the development of policies and priorities for the administration of grants under section 300b&ndash;8 of this title; and</p>
<p class="statutory-body-1em">(3) provide such recommendations, advice or information as may be necessary to enhance, expand or improve the ability of the Secretary to reduce the mortality or morbidity from heritable disorders.</p>
<h4 class="subsection-head">(c) Membership</h4>
<h4 class="paragraph-head">(1) In general</h4>
<p class="statutory-body-1em">The Secretary shall appoint not to exceed 15 members to the Advisory Committee. In appointing such members, the Secretary shall ensure that the total membership of the Advisory Committee is an odd number.</p>
<h4 class="paragraph-head">(2) Required members</h4>
<p class="statutory-body-1em">The Secretary shall appoint to the Advisory Committee under paragraph (1)&mdash;</p>
<p class="statutory-body-2em">(A) the Administrator of the Health Resources and Services Administration;</p>
<!-- PDFPage:786 --><p class="statutory-body-2em">(B) the Director of the Centers for Disease Control and Prevention;</p>
<p class="statutory-body-2em">(C) the Director of the National Institutes of Health;</p>
<p class="statutory-body-2em">(D) the Director of the Agency for Healthcare Research and Quality;</p>
<p class="statutory-body-2em">(E) medical, technical, or scientific professionals with special expertise in heritable disorders, or in providing screening, counseling, testing or specialty services for newborns and children at risk for heritable disorders;</p>
<p class="statutory-body-2em">(F) members of the public having special expertise about or concern with heritable disorders; and</p>
<p class="statutory-body-2em">(G) representatives from such Federal agencies, public health constituencies, and medical professional societies as determined to be necessary by the Secretary, to fulfill the duties of the Advisory Committee, as established under subsection (b) of this section.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title XI, &sect;1111, as added Pub. L. 106&ndash;310, div. A, title XXVI, &sect;2601, Oct. 17, 2000, 114 Stat. 1166.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:priorprovisions-note -->
<h4 class="note-head">Prior Provisions</h4>
<p class="note-body">Prior sections 300c to 300c&ndash;4 were repealed by Pub. L. 94&ndash;278, title IV, &sect;403(a), Apr. 22, 1976, 90 Stat. 407.</p>
<p class="note-body">Section 300c, act July 1, 1944, ch. 373, title XI, &sect;1111, as added Aug. 29, 1972, Pub. L. 92&ndash;414, &sect;3, 86 Stat. 650, authorized Secretary to make grants and enter contracts with public and private entities for establishment of screening, treatment, and counseling programs with respect to Cooley's Anemia.</p>
<p class="note-body">Section 300c&ndash;1, act July 1, 1944, ch. 373, title XI, &sect;1112, as added Aug. 29, 1972, Pub. L. 92&ndash;414, &sect;3, 86 Stat. 651, required that any participation by an individual in any Cooley's Anemia programs should be on a purely voluntary basis.</p>
<p class="note-body">Section 300c&ndash;2, act July 1, 1944, ch. 373, title XI, &sect;1113, as added Aug. 29, 1972, Pub. L. 92&ndash;414, &sect;3, 86 Stat. 651, provided for making of grant upon application to Secretary and listed certain requirements to be met by applicant.</p>
<p class="note-body">Section 300c&ndash;3, act July 1, 1944, ch. 373, title XI, &sect;1114, as added Aug. 29, 1972, Pub. L. 92&ndash;414, &sect;3, 86 Stat. 652, authorized Secretary to establish a program with Public Health Service to provide for screening, counseling, and treatment with respect to Cooley's Anemia.</p>
<p class="note-body">Section 300c&ndash;4, act July 1, 1944, ch. 373, title XI, &sect;1115, as added Aug. 29, 1972, Pub. L. 92&ndash;414, &sect;3, 86 Stat. 652, provided for Secretary's submission of a report to President for transmittal to Congress annually.</p>
<!-- field-end:priorprovisions-note -->
<!-- field-start:terminationdate-note -->
<h4 class="note-head">Termination of Advisory Committees</h4>
<p class="note-body">Advisory committees established after Jan. 5, 1973, to terminate not later than the expiration of the 2-year period beginning on the date of their establishment, unless, in the case of a committee established by the President or an officer of the Federal Government, such committee is renewed by appropriate action prior to the expiration of such 2-year period, or in the case of a committee established by the Congress, its duration is otherwise provided by law. See section 14 of Pub. L. 92&ndash;463, Oct. 6, 1972, 86 Stat. 776, set out in the Appendix to Title 5, Government Organization and Employees.</p>
<p class="note-body">Pub. L. 93&ndash;641, &sect;6, Jan. 4, 1975, 88 Stat. 2275, set out as a note under section 217a of this title, provided that an advisory committee established pursuant to the Public Health Service Act shall terminate at such time as may be specifically prescribed by an Act of Congress enacted after Jan. 4, 1975.</p>
<!-- field-end:terminationdate-note -->
<!-- field-end:notes -->


</body></html>
